Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
2.650
+0.070 (2.71%)
Jul 16, 2026, 11:04 AM EDT - Market open
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $1.11 million as of July 16, 2026. Its market cap has decreased by -83.83% in one year.
Market Cap
1.11M
Enterprise Value
657.01K
1-Year Change
-83.83%
Ranking
Category
Stock Price
$2.65
ChartMarket Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.54M to $1.11M, a decrease of -99.25%. That is a compound annual growth rate of -60.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.05M | -82.55% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.32% |
| Dec 21, 2023 | 41.98M | -71.93% |
| Dec 30, 2022 | 149.58M | 4.03% |
| Dec 31, 2021 | 143.79M | -3.20% |
| Apr 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SciSparc | 2.62M |
| Calidi Biotherapeutics | 2.58M |
| Oragenics | 2.57M |
| VivoSim Labs | 2.34M |
| Bone Biologics | 2.33M |
| Azitra | 2.11M |
| Biodexa Pharmaceuticals | 1.91M |
| CDT Equity | 1.74M |